Zika Virus Infection

Abstract

AbstractZika virus is an emerging mosquito-borne virus that was first identified in Uganda in 1947 in rhesus monkeys. People with Zika virus disease usually have symptoms that can include mild fever, skin rashes, conjunctivitis, muscle and joint pain, malaise or headache. These symptoms normally last for 2-7 days. There is nospecific treatment or vaccine currently available. The best form of prevention is protection against mosquito bites. During Zika outbreaks one can note the association between congenital infection and microcephaly at newborn.

Keywords

• Zika virus,infection,micro-cephaly,Guillain-Barré

Zika Virus Enfeksiyonu

Öz

Öz

Zika virus ilk kez Uganda’da 1947 yılında Rhesus maymununda tanımlanmış sivrisineklerle bulaşan bir enfeksiyon hastalığıdır. Hastalık hafif ateş, deri döküntüsü,konjunktivit, kas ve eklem ağrısı, halsizlik ve başağrısı gibi bulgularla seyreder. Bubulgular 2-7 gün sürer. Spesifik bir tedavisi veya aşısı yoktur. Korunmak için en ideal yol sivrisineklerle savaştır. Zika salgınları sırasında konjenital enfeksiyon ile yenidoğan mikrosefalisi arasında önemli bir ilişki saptanmıştır.

Anahtar Kelimeler

• Zika virus,enfeksiyon,mikrose-fali,Guillain-Barré

References

1. Kaynaklar 1.Petersen LR, Jamieson DJ, Power AM, Honein MA.Zika virus. N Engl J Med 2016; 374: 1552. 2World Health Organization. Emergencies: The historyof Zika virus. http://www.who.int/emergencies/zika-vi-rus/timeline/en/ (Accessed on February 25, 2016). 3.Duffy MR, Chen TH, Hancock WT, et al. Zika virusoutbreak on Yap Island. Federated States of Micro-nesia. N Engl J Med 2009; 360: 2536. 4.Cauchemez S, Besnard M, Bompard P, et al. Associa-ted between Zika virus and microcephaly in FrenchPolynesia. 2013-15: e retrospective study. Lancet 2016;387: 2125. 5.Gatherer D, Kohl A. Zika virus: a previously slow pan-demic spreads rapidly through the Americas. J Gen Vi-rol 2016; 97: 269. 6.Hennessey M, Fisher M, StapllesJE. Zika Virus Spre-ad to New Areas- Region of the Americas. May 2015-January 2016. MMWR Morb Mortal Wkly Rep 2016;65: 55. 7.Musso D, Nhan T, Robin E, et al. Potential for Zikavirus transmission through blood transfusion de-monstrated during an outbreak in French Polynesia.November 2013 to February 2014. Euro Surveillan-ce 2014; 19. 8.Center for Disease Control and Prevention. Zika vi-rus: Transmission. http://www.cdc.gov/zika/trans-mission/index.html (Accessed on February 03, 2016). 9.Davidson A, Slavinski S, Komoto K, et al. Suspected female-to-male sexual transmission of Zika virus - NewYork City, 2016. MMWR Morb Mortal Wkly Rep 2016;65: 716. 10.Motta IJ, Spencer BR, Cordeiro da Silva SG, et al. Evi-dence for transmission of Zika virus by platelettransfusion. N Engl J Med 2016; 375: 1101. 11.Center for Disease Control and Prevention. Zika vi-rus: For Health Care Providers: Clinical Evaluation& Disease. http://www.cdc.gov/zika/hc-providers/cli-nicalevaluation.htlm (Accessed on January 13, 2016). 12.Sarmiento-Ospina A. Vasquez-Serna H, Jimenez-Canizales CE, et al. Zika virus associated deaths inColombia. Lancet Infect Dis 2016; 16: 523. 13.Fleming-Dutra KE, Nelson JM. Fischer M, et al. Up-date: Interim Guidelines for Health Care Providers Ca-ring for Infants and Children with Possible Zika virusInfection--United States. February 2016. MMWRMorb Mortal Wkly Rep 2016; 65: 182. 14.Center for Disease Control and Prevention. Zika vi-rus: For Health Care Providers: Diagnostic Testinghttp://www.cdc. gov/zika/hc-providers/diagnostic.htlm (Accessed on January 13, 2016). 15.Rabe IB, Staples JE, Villaneuva J, et al. Interim gui-dance for interpretation of Zika virus antibody test re-sults. MMWR Morb Mortal Wkly Rep 2016; 65: 543. 16.Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zikavirus impairs growth in human neurospheres and bra-in organoids. Science 2016; 352: 816. 17.Ramussen SA, Jamieson DJ, Honein MA, Peterson LR.Zika virus and birth defects-- Reviewing the eviden-ce for causality. N Engl J Med 2016; 374: 1981. 18.Ventura CV, Maia M, Dias N, et al. Zika: neurologi-cal and ocular findings in infant without microcephaly.Lancet 2016; 387: 2502. 19.Russel K, Oliver SE, Lewis L, et AL. Update: Interimguidance for the evaluation and management of infantswith possible congenital Zika virus infection -UnitedStates. August 2016. MMWR Morb Mortal Wkly Rep2016; 65. 20.de Fatima Vasco Aragao M, van der Linden V, Brai-ner-Lima AM, et al. Clinical features and neuroima-ging (CT and MRI) findings in presumed Zika virusrelated congenital infection and microcephaly: retros-pective case series study. BJM 2016; 353: 1901. 21.Soares de Oliverira-Szeinfeld P, Levine D, Melo AS,et al. Congenital brain abnormalities and Zika virus:What the radiologist can expect to see prenatally andpostnatally. Radiology 2016; 281: 203. 22.Vouga M, Baud D. Imaging of congenital Zika virusinfection: the route to identification of prognostic fac-tors. Prenat Diagn 2016; 36: 799.